- Bayer loses 2% after jury verdict
General market situation:
Monday's session on European stock markets brings moderate declines in most stock indexes. Germany's DAX is currently gaining 0.33%. Britain's FTSE 100 is losing more than 0.07% at the same time. The French CAC40, meanwhile, is down 0.35%. Investor attention today turns to corporate news and speeches by Fed bankers.
Start investing today or test a free demo
Create account Try a demo Download mobile app Download mobile app
Volatility currently observed in the broad European market. Source: xStation
The German benchmark DE40 is trading nearly 0.15% higher during Monday's session. It seems that the key support points of the broad uptrend remain the zones of recent peaks (19,000 points) and the 50-day EMA (blue curve on the chart). The most important resistance, on the other hand, remains the historical peak near 19,650 points. Source: xStation
News:
Bayer (BAYN.DE) shares are down 2%,after a Philadelphia state court jury returned a verdict in favor of a Pennsylvania man who blamed the company for causing non-Hodgkin's lymphoma through the German company's Roundup herbicide. The jury awarded the victim $3 million in compensatory damages and $75 million in punitive damages, according to a statement issued by lawyers.
Shares of French banks and financial companies are under slight downward pressure today after Fitch Ratings gave France a negative outlook, saying it is not convinced the 2025 budget will prevent a surge in public debt. French banks such as BNP Paribas, Societe Generale, Credit Agricole and insurers such as Axa are generally exposed to both the decline in the value of French government bonds and the premium investors demand to hold them.
Equinor (EQNR.NO) was upgraded to an “equal-weight” rating by Morgan Stanley, although the investment bank maintains an overall cautious stance on the European energy sector, based on the weak outlook for oil through 2025.
Other news coming out of individual DAX index companies. Source: Bloomberg Financial LP
The content of this report has been created by XTB S.A., with its registered office in Warsaw, at Prosta 67, 00-838 Warsaw, Poland, (KRS number 0000217580) and supervised by Polish Supervision Authority ( No. DDM-M-4021-57-1/2005). This material is a marketing communication within the meaning of Art. 24 (3) of Directive 2014/65/EU of the European Parliament and of the Council of 15 May 2014 on markets in financial instruments and amending Directive 2002/92/EC and Directive 2011/61/EU (MiFID II). Marketing communication is not an investment recommendation or information recommending or suggesting an investment strategy within the meaning of Regulation (EU) No 596/2014 of the European Parliament and of the Council of 16 April 2014 on market abuse (market abuse regulation) and repealing Directive 2003/6/EC of the European Parliament and of the Council and Commission Directives 2003/124/EC, 2003/125/EC and 2004/72/EC and Commission Delegated Regulation (EU) 2016/958 of 9 March 2016 supplementing Regulation (EU) No 596/2014 of the European Parliament and of the Council with regard to regulatory technical standards for the technical arrangements for objective presentation of investment recommendations or other information recommending or suggesting an investment strategy and for disclosure of particular interests or indications of conflicts of interest or any other advice, including in the area of investment advisory, within the meaning of the Trading in Financial Instruments Act of 29 July 2005 (i.e. Journal of Laws 2019, item 875, as amended). The marketing communication is prepared with the highest diligence, objectivity, presents the facts known to the author on the date of preparation and is devoid of any evaluation elements. The marketing communication is prepared without considering the client’s needs, his individual financial situation and does not present any investment strategy in any way. The marketing communication does not constitute an offer of sale, offering, subscription, invitation to purchase, advertisement or promotion of any financial instruments. XTB S.A. is not liable for any client’s actions or omissions, in particular for the acquisition or disposal of financial instruments, undertaken on the basis of the information contained in this marketing communication. In the event that the marketing communication contains any information about any results regarding the financial instruments indicated therein, these do not constitute any guarantee or forecast regarding the future results.
